Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
European Journal of Pharmacology
|
May 11, 2013
α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain
Ramakrishna Nirogi, Venkatesh Goura, Renny Abraham, et al.
Behavioural Pharmacology
|
October 14, 2025
5-Hydroxytryptamine 7 receptor agonist LP-211 in combination with gabapentin ameliorates neuropathic pain comorbidities associated with mechanical allodynia in diabetic and nerve-ligated rats
Venkatesh Goura, Pradeep Jayarajan, Anoop Kishore, et al.
Journal of Pharmacological and Toxicological Methods
|
May 12, 2012
Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats
Ramakrishna Nirogi, Venkatesh Goura, Dhanalakshmi Shanmuganathan, et al.
Pharmacological Reports : PR
|
September 24, 2015
5-HT6 receptor antagonist attenuates the memory deficits associated with neuropathic pain and improves the efficacy of gabapentinoids
Pradeep Jayarajan, Ramakrishna Nirogi, Anil Shinde, et al.
European Journal of Pharmacology
|
July 16, 2011
Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain
Ramakrishna Nirogi, Sugin Lal Jabaris, Pradeep Jayarajan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Vijay Benade, Anil Shinde, Rajesh Kumar Badange, et al.
Psychopharmacology
|
March 17, 2022
Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization
Ramakrishna Nirogi, Renny Abraham, Pradeep Jayarajan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Renny Abraham, Venkatesh Goura, Rajesh Kallepalli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
European Journal of Pharmacology
|
May 11, 2013
α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain
Ramakrishna Nirogi, Venkatesh Goura, Renny Abraham, et al.
Behavioural Pharmacology
|
October 14, 2025
5-Hydroxytryptamine 7 receptor agonist LP-211 in combination with gabapentin ameliorates neuropathic pain comorbidities associated with mechanical allodynia in diabetic and nerve-ligated rats
Venkatesh Goura, Pradeep Jayarajan, Anoop Kishore, et al.
Journal of Pharmacological and Toxicological Methods
|
May 12, 2012
Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats
Ramakrishna Nirogi, Venkatesh Goura, Dhanalakshmi Shanmuganathan, et al.
Pharmacological Reports : PR
|
September 24, 2015
5-HT6 receptor antagonist attenuates the memory deficits associated with neuropathic pain and improves the efficacy of gabapentinoids
Pradeep Jayarajan, Ramakrishna Nirogi, Anil Shinde, et al.
European Journal of Pharmacology
|
July 16, 2011
Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain
Ramakrishna Nirogi, Sugin Lal Jabaris, Pradeep Jayarajan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Vijay Benade, Anil Shinde, Rajesh Kumar Badange, et al.
Psychopharmacology
|
March 17, 2022
Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization
Ramakrishna Nirogi, Renny Abraham, Pradeep Jayarajan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Renny Abraham, Venkatesh Goura, Rajesh Kallepalli, et al.
Page
of 1